Picture EBD Group BioTech Showcase 2022 For Investors 650x100
Organisation › Details

Syncona (Group)

Syncona’s purpose is to invest to extend and enhance human life. We do this by founding and building a portfolio of global leaders in life science to deliver transformational treatments to patients in areas of high unmet need. Our strategy is to found, build and fund companies around exceptional science to create a diversified portfolio of 15-20 globally leading healthcare businesses for the benefit of all our stakeholders. We focus on developing treatments for patients by working in close partnership with world-class academic founders and management teams. Our balance sheet underpins our strategy enabling us to take a long-term view as we look to improve the lives of patients with no or poor treatment options, build sustainable life science companies and deliver strong risk-adjusted returns to shareholders. *


Period Start 2018-11-21 existent
Products Industry venture capital
  Industry 2 LIFE SCIENCES
Region Region Guernsey
  Country United Kingdom (GB)
  Street St Julian’s Avenue, St Peter Port
Arnold House, PO Box 273
  City GY1 3RD Guernsey, Channel Islands
    Address record changed: 2021-11-13
Basic data Employees n. a.
    * Document for �About Section�: Clade Therapeutics. (11/3/21). "Press Release: Clade Therapeutics Raises $87 Million Series A Financing to Realize the Potential of Cell Therapy". Cambridge, MA.
Record changed: 2021-11-13


Picture Kentro Design Is Key to Your Success Berlin 650x100px

More documents for Syncona (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture EBD Group BioTech Showcase 2022 For Investors 650x300

» top